Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Summer Research Program for Diversity Students in PharmacoNeuroImmunology
Molitor, T. W., Carroll, D. M., Gewirtz, J. C., Hatsukami, D. K. & Pravetoni, M.
7/1/21 → 5/31/26
Project: Research project
-
Adjuvanted Opioid Vaccine for Treating Fentanyl Use Disorder
Pravetoni, M. & Borgatti, A. M.
9/30/20 → 9/29/23
Project: Research project
-
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
Raleigh, M. D. & Pravetoni, M.
Research Foundation for Mental Hygiene
9/1/19 → 8/31/23
Project: Research project
-
Novel nanovaccines against opioid use disorder
Raleigh, M. D., Birnbaum, A. & Pravetoni, M.
VIRGINIA POLYTECHNIC INST. & STATE UNIV.
7/15/19 → 6/30/23
Project: Research project
-
-
Anti-Strychnine Immunoconjugate Reduces the Effects of Strychnine-Induced Toxicity in Mice
Baehr, C., Kassick, A. J., Vigliaturo, J., Luengas, D., Khaimraj, A., Pravetoni, M., Averick, S. E. & Raleigh, M. D., Apr 5 2023, In: ACS Chemical Neuroscience. 14, 7, p. 1291-1298 8 p.Research output: Contribution to journal › Article › peer-review
-
A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl
Triller, G., Vlachou, E. P., Hashemi, H., van Straaten, M., Zeelen, J. P., Kelemen, Y., Baehr, C., Marker, C. L., Ruf, S., Svirina, A., Chandra, M., Urban, K., Gkeka, A., Kruse, S., Baumann, A., Miller, A. K., Bartel, M., Pravetoni, M., Stebbins, C. E., Papavasiliou, F. N., & 1 others, Feb 28 2023, In: Cell reports. 42, 2, 112049.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review
Kiluk, B. D., Kleykamp, B. A., Comer, S. D., Griffiths, R. R., Huhn, A. S., Johnson, M. W., Kampman, K. M., Pravetoni, M., Preston, K. L., Vandrey, R., Bergeria, C. L., Bogenschutz, M. P., Brown, R. T., Dunn, K. E., Dworkin, R. H., Finan, P. H., Hendricks, P. S., Houtsmuller, E. J., Kosten, T. R., Lee, D. C., & 7 others, Jan 4 2023, In: JAMA psychiatry. 80, 1, p. 84-92 9 p.Research output: Contribution to journal › Review article › peer-review
-
IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice
Crouse, B., Baehr, C., Hicks, D. & Pravetoni, M., May 1 2023, In: Journal of Immunology. 210, 9, p. 1272-1280 9 p.Research output: Contribution to journal › Article › peer-review
-
Immunotherapeutic strategies for treating opioid use disorder and overdose
Luba, R., Martinez, S., Jones, J., Pravetoni, M. & Comer, S. D., 2023, In: Expert Opinion on Investigational Drugs. 32, 1, p. 77-87 11 p.Research output: Contribution to journal › Review article › peer-review
Press/Media
-
U of M researchers receive $2.4 million grant to develop fentanyl vaccines and antibodies
10/7/20
1 item of Media coverage
Press/Media: Research